In bispecific rivalry, AbbVie’s Epkinly follows Roche’s Lunsumio into follicular lymphoma

In bispecific rivalry, AbbVie’s Epkinly follows Roche’s Lunsumio into follicular lymphoma aliu Thu, 06/27/2024 - 09:58